Abiomed Inc (ABMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2003 | 09-2003 | 06-2003 | 03-2003 | 12-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,913 | -5,946 | -3,185 | -18,171 | -15,131 |
| Depreciation Amortization | 1,056 | 709 | 359 | 1,704 | 1,325 |
| Accounts receivable | 1,540 | 2,042 | 1,121 | 1,649 | 2,557 |
| Accounts payable and accrued liabilities | -30 | -262 | -132 | -576 | -1,165 |
| Other Working Capital | -591 | -620 | -1,048 | -195 | 727 |
| Other Operating Activity | -1,415 | -1,690 | -926 | -595 | -982 |
| Operating Cash Flow | $-7,353 | $-5,767 | $-3,811 | $-16,184 | $-12,669 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -22,360 | 3,370 | 1,235 | 15,777 | 17,550 |
| PPE Investments | -233 | -181 | -135 | -814 | -665 |
| Purchase Sale Intangibles | -30 | -16 | -9 | -153 | -137 |
| Other Investing Activity | -30 | -16 | -9 | -153 | -137 |
| Investing Cash Flow | $-22,623 | $3,173 | $1,091 | $14,810 | $16,748 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -54 | -54 |
| Common Stock Issued | 614 | 279 | N/A | 333 | 295 |
| Financing Cash Flow | $614 | $279 | $N/A | $279 | $241 |
| Beginning Cash Position | 44,572 | 44,572 | 44,572 | 45,667 | 45,667 |
| End Cash Position | 15,210 | 42,257 | 41,852 | 44,572 | 49,987 |
| Net Cash Flow | $-29,362 | $-2,315 | $-2,720 | $-1,095 | $4,320 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,353 | -5,767 | -3,811 | -16,184 | -12,669 |
| Capital Expenditure | -245 | -181 | -135 | -840 | -691 |
| Free Cash Flow | -7,598 | -5,948 | -3,946 | -17,024 | -13,360 |